Literature DB >> 24779974

Aflatoxin M1 in raw cow and buffalo milk in Shush city of Iran.

Abolfazl Kamkar1, Samira Yazdankhah, Abdolreza Mohammadi Nafchi, Amir Sasan Mozaffari Nejad.   

Abstract

Aflatoxin M1 (AFM1) contamination is evaluated in 120 samples of raw milk from cow and buffalo (60 each), collected randomly in the Shush (southwest Iran). Enzyme-linked immunoabsorbent assay (ELISA) was applied to analyse AFM1 in the samples. AFM1 was detected in 44 (69%) raw cow milk samples with a mean of 55 ng/l at a range of 3.6-419 ng/l) and in 46 (79%) raw buffalo milk samples with a mean of 116 ng/l at a range of 13-423 ng/l. In all samples, the AFM1 concentration was lower than the Iranian national standard and FDA limit of 500 ng/l. According to the European Union and Codex Alimentarius Commission, 18 (28%) and 32 (52%) of cow and buffalo raw milk samples are above the 50 ng/l limit, respectively. Results showed that AFM1 contamination of raw milk could pose a problem for public health, since all age groups, including infants and children, consume this product.

Entities:  

Keywords:  Aflatoxin M1; ELISA; Iran; buffalo; cow; raw milk

Mesh:

Substances:

Year:  2013        PMID: 24779974     DOI: 10.1080/19393210.2013.830277

Source DB:  PubMed          Journal:  Food Addit Contam Part B Surveill        ISSN: 1939-3210            Impact factor:   3.407


  3 in total

1.  Detection of aflatoxin M1 in milk and milk products in Turkey.

Authors:  Funda Yilmaz Eker; Karlo Muratoglu; Ayşe Gülin Eser
Journal:  Environ Monit Assess       Date:  2019-07-29       Impact factor: 2.513

2.  Assessment of AflatoxinM1 Contamination in UHT Flavored Milk Samples in Karaj, Iran.

Authors:  Zohreh Mashak; Hadi Jafari Sohi; Ali Heshmati; Amir Sasan Mozaffari Nejad
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

3.  The Occurrence and Risk Assessment of Exposure to Aflatoxin M1 in Ultra-High Temperature and Pasteurized Milk in Hamadan Province of Iran.

Authors:  Amir Sasan Mozaffari Nejad; Ali Heshmati; Tayebe Ghiasvand
Journal:  Osong Public Health Res Perspect       Date:  2019-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.